These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
650 related articles for article (PubMed ID: 25607647)
1. The synergistic inhibition of breast cancer proliferation by combined treatment with 4EGI-1 and MK2206. Wang H; Huang F; Wang J; Wang P; Lv W; Hong L; Li S; Zhou J Cell Cycle; 2015; 14(2):232-42. PubMed ID: 25607647 [TBL] [Abstract][Full Text] [Related]
2. Feedback loops blockade potentiates apoptosis induction and antitumor activity of a novel AKT inhibitor DC120 in human liver cancer. Yang F; Deng R; Qian XJ; Chang SH; Wu XQ; Qin J; Feng GK; Ding K; Zhu XF Cell Death Dis; 2014 Mar; 5(3):e1114. PubMed ID: 24625973 [TBL] [Abstract][Full Text] [Related]
3. AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis. Mi W; Ye Q; Liu S; She QB Oncotarget; 2015 Jun; 6(16):13962-77. PubMed ID: 25961827 [TBL] [Abstract][Full Text] [Related]
4. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583 [TBL] [Abstract][Full Text] [Related]
5. Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. Kazyken D; Lentz SI; Wadley M; Fingar DC J Biol Chem; 2023 Sep; 299(9):105097. PubMed ID: 37507012 [TBL] [Abstract][Full Text] [Related]
6. A dual mTORC1 and mTORC2 inhibitor shows antitumor activity in esophageal squamous cell carcinoma cells and sensitizes them to cisplatin. Huang Y; Xi Q; Chen Y; Wang J; Peng P; Xia S; Yu S Anticancer Drugs; 2013 Oct; 24(9):889-98. PubMed ID: 23838676 [TBL] [Abstract][Full Text] [Related]
7. Anti-Cancer Effect of Cap-Translation Inhibitor 4EGI-1 in Human Glioma U87 Cells: Involvement of Mitochondrial Dysfunction and ER Stress. Wu M; Zhang C; Li XJ; Liu Q; Wanggou S Cell Physiol Biochem; 2016; 40(5):1013-1028. PubMed ID: 27941351 [TBL] [Abstract][Full Text] [Related]
8. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280 [TBL] [Abstract][Full Text] [Related]
9. GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition. Ito H; Ichiyanagi O; Naito S; Bilim VN; Tomita Y; Kato T; Nagaoka A; Tsuchiya N BMC Cancer; 2016 Jul; 16():393. PubMed ID: 27387559 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma. Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation. George A; Panda S; Kudmulwar D; Chhatbar SP; Nayak SC; Krishnan HH J Biol Chem; 2012 Feb; 287(7):5042-58. PubMed ID: 22184107 [TBL] [Abstract][Full Text] [Related]
12. Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway. Bommer UA; Iadevaia V; Chen J; Knoch B; Engel M; Proud CG Cell Signal; 2015 Aug; 27(8):1557-68. PubMed ID: 25936523 [TBL] [Abstract][Full Text] [Related]
13. HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation. Chen B; Zhao J; Zhang S; Zhang Y; Huang Z Oncol Rep; 2016 Dec; 36(6):3664-3672. PubMed ID: 27748944 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of mTORC2 Induces Cell-Cycle Arrest and Enhances the Cytotoxicity of Doxorubicin by Suppressing MDR1 Expression in HCC Cells. Chen BW; Chen W; Liang H; Liu H; Liang C; Zhi X; Hu LQ; Yu XZ; Wei T; Ma T; Xue F; Zheng L; Zhao B; Feng XH; Bai XL; Liang TB Mol Cancer Ther; 2015 Aug; 14(8):1805-15. PubMed ID: 26026051 [TBL] [Abstract][Full Text] [Related]
15. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells. Misra UK; Pizzo SV PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152 [TBL] [Abstract][Full Text] [Related]
16. Ubiquilin-mediated Small Molecule Inhibition of Mammalian Target of Rapamycin Complex 1 (mTORC1) Signaling. Coffey RT; Shi Y; Long MJ; Marr MT; Hedstrom L J Biol Chem; 2016 Mar; 291(10):5221-33. PubMed ID: 26740621 [TBL] [Abstract][Full Text] [Related]
17. Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models. Gökmen-Polar Y; Liu Y; Toroni RA; Sanders KL; Mehta R; Badve S; Rommel C; Sledge GW Breast Cancer Res Treat; 2012 Dec; 136(3):673-82. PubMed ID: 23085766 [TBL] [Abstract][Full Text] [Related]
18. Parallel PI3K, AKT and mTOR inhibition is required to control feedback loops that limit tumor therapy. Sathe A; Chalaud G; Oppolzer I; Wong KY; von Busch M; Schmid SC; Tong Z; Retz M; Gschwend JE; Schulz WA; Nawroth R PLoS One; 2018; 13(1):e0190854. PubMed ID: 29357370 [TBL] [Abstract][Full Text] [Related]
19. 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma. De A; Jacobson BA; Peterson MS; Jay-Dixon J; Kratzke MG; Sadiq AA; Patel MR; Kratzke RA Invest New Drugs; 2018 Apr; 36(2):217-229. PubMed ID: 29116477 [TBL] [Abstract][Full Text] [Related]
20. A comparison of Ku0063794, a dual mTORC1 and mTORC2 inhibitor, and temsirolimus in preclinical renal cell carcinoma models. Zhang H; Berel D; Wang Y; Li P; Bhowmick NA; Figlin RA; Kim HL PLoS One; 2013; 8(1):e54918. PubMed ID: 23349989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]